Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000934936-08-000015
Filing Date
2008-03-11
Accepted
2008-03-11 15:08:25
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form_10-k.htm 10-K 1771500
2 CERTIFICATE OF DESIGNATION OF SERIES A JUNIOR PARTICIPATING PREFERRED STOCK exhibit_4-2.htm EX-4.2 179195
3 RIGHTS AGREEMENT exhibit_4-4.htm EX-4.4 453380
4 WARRANT AGREEMENT exhibit_10-3.htm EX-10.3 260899
5 CONSENT OF GRANT THORNTON LLP exhibit_23-1.htm EX-23.1 2953
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exhibit_31-1.htm EX-31.1 16948
7 CONSENT OF CHIEF FINANCIAL OFFICER exhibit_31-2.htm EX-31.2 17174
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exhibit_32-1.htm EX-32.1 6642
9 CONSENT OF CHIEF FINANCIAL OFFICER exhibit_32-2.htm EX-32.2 6849
10 GRAPH stockholdersgraph.jpg GRAPHIC 25647
  Complete submission text file 0000934936-08-000015.txt   2752744
Mailing Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006
Business Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006 4253730171
SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)

EIN.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31982 | Film No.: 08680414
SIC: 2835 In Vitro & In Vivo Diagnostic Substances